I watched it and the mgmt confidence in the results including safety is really high. The primary focus will be on TGA and subsequently FDA engagement/ approval.
On commercial front Tom spoke highly of Neuren and GW pharma (drug epidiolex, which was acquired by Jazz pharma). This is the most exciting bit for me as a new SH.
